{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:08:37Z","timestamp":1790003317303,"version":"4.0.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"National Institutes of Health Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Methods"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.crmeth.2026.101513","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:47:00Z","timestamp":1783439220000},"page":"101513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TACTIC: A transfer learning framework to predict drug interactions in emerging pathogens"],"prefix":"10.1016","volume":"6","author":[{"given":"Carolina H.","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Rhoads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajna","family":"Lalitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunasekaran","family":"Rameshkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajarathinam","family":"Karpagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojkumar","family":"Vimaladevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline R.","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy A.","family":"Okezue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanuz","family":"Dechayont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlee D.","family":"Brunaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8405-5708","authenticated-orcid":false,"given":"Sriram","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmeth.2026.101513_bib1","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (2019). Antibiotic Resistance Threats in the United States https:\/\/doi.org\/10.15620\/cdc:82532.","DOI":"10.15620\/cdc:82532"},{"key":"10.1016\/j.crmeth.2026.101513_bib2","doi-asserted-by":"crossref","unstructured":"World Health Organization (2014). Antimicrobial resistance: global report on surveillance https:\/\/doi.org\/10.1007\/s13312-014-0374-3.","DOI":"10.1007\/s13312-014-0374-3"},{"key":"10.1016\/j.crmeth.2026.101513_bib3","series-title":"Antibiotics: Past, Present and Future","author":"Hutchings","year":"2019"},{"key":"10.1016\/j.crmeth.2026.101513_bib4","series-title":"Drug Combinations: A Strategy to Extend the Life of Antibiotics in the 21st Century","author":"Tyers","year":"2019"},{"key":"10.1016\/j.crmeth.2026.101513_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cels.2015.12.003","article-title":"Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning","volume":"1","author":"Wildenhain","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.crmeth.2026.101513_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001644","article-title":"High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance","volume":"15","author":"Wambaugh","year":"2017","journal-title":"PLoS Biol."},{"key":"10.1016\/j.crmeth.2026.101513_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215607","article-title":"Artificial intelligence enabled parabolic response surface platform identifies ultra-rapid near-universal TB drug treatment regimens comprising approved drugs","volume":"14","author":"Clemens","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.crmeth.2026.101513_bib8","first-page":"1","article-title":"Machine learning approaches for drug combination therapies","volume":"22","author":"G\u00fcven\u00e7 Paltun","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.crmeth.2026.101513_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105070118","article-title":"Deep learning identifies synergistic drug combinations for treating COVID-19","volume":"118","author":"Jin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2026.101513_bib10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-21-0832","article-title":"Precision Combination Therapies Based on Recurrent Oncogenic Coalterations","volume":"12","author":"Li","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.crmeth.2026.101513_bib11","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.drudis.2022.04.006","article-title":"Machine learning to design antimicrobial combination therapies: Promises and pitfalls","volume":"27","author":"Cantrell","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.crmeth.2026.101513_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/nyas.14930","article-title":"Antibiotic discovery in the artificial intelligence era","volume":"1519","author":"Lluka","year":"2023","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.crmeth.2026.101513_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.adh1114","article-title":"Leveraging artificial intelligence in the fight against infectious diseases","volume":"381","author":"Wong","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101513_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.15252\/msb.20156777","article-title":"Chemogenomics and orthology-based design of antibiotic combination therapies","volume":"12","author":"Chandrasekaran","year":"2016","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.crmeth.2026.101513_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02627-19","article-title":"Transcriptomic signatures predict regulators of drug synergy and clinical regimen efficacy against tuberculosis","volume":"10","author":"Ma","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.crmeth.2026.101513_bib16","series-title":"Handbook of research on machine applications and trends: algorithms, methods, and techniques","first-page":"242","article-title":"Transfer learning","author":"Torrey","year":"2010"},{"key":"10.1016\/j.crmeth.2026.101513_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tube.2012.01.005","article-title":"Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis","volume":"92","author":"Rey-Jurado","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.crmeth.2026.101513_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2012.11.011","article-title":"In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates","volume":"41","author":"Rey-Jurado","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.crmeth.2026.101513_bib19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41564-018-0252-1","article-title":"Additivity of inhibitory effects in multidrug combinations","volume":"3","author":"Russ","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib20","doi-asserted-by":"crossref","first-page":"E2172","DOI":"10.1073\/pnas.1600812113","article-title":"Output-driven feedback system control platform optimizes combinatorial therapy of tuberculosis using a macrophage cell culture model","volume":"113","author":"Silva","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2026.101513_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ng1755","article-title":"Functional classification of drugs by properties of their pairwise interactions","volume":"38","author":"Yeh","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.crmeth.2026.101513_bib22","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1038\/s41598-019-48410-y","article-title":"Design of high-order antibiotic combinations against M. tuberculosis by ranking and exclusion","volume":"9","author":"Yilancioglu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmeth.2026.101513_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijid.2016.08.027","article-title":"Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo","volume":"52","author":"Zhao","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.crmeth.2026.101513_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2005.05.005","article-title":"Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis","volume":"26","author":"Bhusal","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.crmeth.2026.101513_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-018-0278-9","article-title":"Species-specific activity of antibacterial drug combinations","volume":"559","author":"Brochado","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2026.101513_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jgar.2019.06.013","article-title":"In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates","volume":"19","author":"Chandramohan","year":"2019","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.crmeth.2026.101513_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fmicb.2015.00330","article-title":"Enhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from Brazil","volume":"6","author":"Coelho","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006677","article-title":"Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment","volume":"14","author":"Cokol","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.crmeth.2026.101513_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijantimicag.2014.11.017","article-title":"Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis","volume":"45","author":"Gonzalo","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.crmeth.2026.101513_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006774","article-title":"Prediction of ultra-high-order antibiotic combinations based on pairwise interactions","volume":"15","author":"Katzir","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.crmeth.2026.101513_bib31","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/AAC.02463-14","article-title":"Antagonism between bacteriostatic and bactericidal antibiotics is prevalent","volume":"58","author":"Ocampo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01952257","article-title":"\u00dcber Kombinationswirkungen - Mitteilung: Hilfsmittel der Fragestellung","volume":"114","author":"Loewe","year":"1926","journal-title":"Archiv f. experiment. Pathol. u. Pharmakol."},{"key":"10.1016\/j.crmeth.2026.101513_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The Toxicity of Poisons Applied Jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."},{"key":"10.1016\/j.crmeth.2026.101513_bib34","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41564-023-01486-9","article-title":"Systematic analysis of drug combinations against Gram-positive bacteria","volume":"8","author":"Cacace","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2008.09.038","article-title":"Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death","volume":"135","author":"Kohanski","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2026.101513_bib37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1574-6976.2011.00282.x","article-title":"Metabolic regulation of antibiotic resistance","volume":"35","author":"Mart\u00ednez","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.crmeth.2026.101513_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.mib.2009.06.018","article-title":"Role of reactive oxygen species in antibiotic action and resistance","volume":"12","author":"Dwyer","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.chom.2017.10.020","article-title":"Antibiotic-Induced Changes to the Host Metabolic Environment Inhibit Drug Efficacy and Alter Immune Function","volume":"22","author":"Yang","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.crmeth.2026.101513_bib40","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41564-019-0536-0","article-title":"Bacterial metabolic state more accurately predicts antibiotic lethality than growth rate","volume":"4","author":"Lopatkin","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac132","article-title":"A flux-based machine learning model to simulate the impact of pathogen metabolic heterogeneity on drug interactions","volume":"1","author":"Chung","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.crmeth.2026.101513_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00159-24","article-title":"Critical role of growth medium for detecting drug interactions in Gram-negative bacteria that model in vivo responses","volume":"15","author":"Davis","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.crmeth.2026.101513_bib43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib44","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3389\/fmicb.2020.02029","article-title":"Species-Level Analysis of Human Gut Microbiota With Metataxonomics","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib45","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41467-022-29096-9","article-title":"Strain-level characterization of broad host range mobile genetic elements transferring antibiotic resistance from the human microbiome","volume":"13","author":"Forster","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101513_bib46","series-title":"The Microbiome and Tuberculosis: Early Evidence for Cross Talk","author":"Namasivayam","year":"2018"},{"key":"10.1016\/j.crmeth.2026.101513_bib47","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1038\/s41467-020-18871-1","article-title":"Health and disease markers correlate with gut microbiome composition across thousands of people","volume":"11","author":"Manor","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.crmeth.2026.101513_bib48","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41564-021-00912-0","article-title":"Gut microbiome alterations in high-fat-diet-fed mice are associated with antibiotic tolerance","volume":"6","author":"Liu","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41579-021-00667-9","article-title":"Microbiome-based therapeutics","volume":"20","author":"Sorbara","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib50","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.cels.2021.08.004","article-title":"Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis","volume":"12","author":"Larkins-Ford","year":"2021","journal-title":"Cell Syst."},{"key":"10.1016\/j.crmeth.2026.101513_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.0954-6820.1982.tb03233.x","article-title":"Combination of Amikacin and either Ampicillin or Cephalotin as Initial Treatment of Febrile Neutropenic Patients","volume":"212","author":"Palmblad","year":"1982","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.crmeth.2026.101513_bib52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00006454-199003000-00006","article-title":"Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections","volume":"9","author":"Uma\u00f1a","year":"1990","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.crmeth.2026.101513_bib53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.crmeth.2026.101513_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.rvsc.2017.12.010","article-title":"Pharmacodynamic interactions of amikacin with selected \u03b2-lactams and fluoroquinolones against canine Escherichia coli isolates","volume":"117","author":"Delis","year":"2018","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.crmeth.2026.101513_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/AAC.25.2.283","article-title":"In vitro activity of aztreonam in combination with newer \u03b2-lactams and amikacin against multiply resistant gram-negative bacilli","volume":"25","author":"Buesing","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/antibiotics9080475","article-title":"Antimicrobials as single and combination therapy for colistin-resistant pseudomonas aeruginosa at a university hospital in Thailand","volume":"9","author":"Pungcharoenkijkul","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.crmeth.2026.101513_bib57","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/AAC.31.9.1403","article-title":"In vitro activity of aztreonam combined with tobramycin and gentamicin against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis","volume":"31","author":"Bosso","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/sur.2009.9930","article-title":"Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"11","author":"Solomkin","year":"2010","journal-title":"Surg. Infect."},{"key":"10.1016\/j.crmeth.2026.101513_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00425-19","article-title":"Comparable Efficacy and Better Safety of Double -Lactam Combination Therapy versus -Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials","volume":"63","author":"Jiao","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45550-z","article-title":"Dual \u03b2-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition","volume":"9","author":"Siriyong","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmeth.2026.101513_bib61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.crmeth.2026.101513_bib62","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1001\/archinte.162.15.1746","article-title":"Sixty-three cases of Mycobacterium marinum infection: Clinical features, treatment, and antibiotic susceptibility of causative isolates","volume":"162","author":"Aubry","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.crmeth.2026.101513_bib63","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/infdis\/171.3.747","article-title":"Reduced serum levels of clarithromycin in patients treated with multi-drug regimens including rifampin or rifabutin for mycobacterium avium-m. Intracellulare infection","volume":"171","author":"Wallace","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.crmeth.2026.101513_bib64","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/AAC.02165-13","article-title":"Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease","volume":"58","author":"Phillips","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib65","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/1346-8138.13049","article-title":"Revisiting Buruli ulcer","volume":"42","author":"Yotsu","year":"2015","journal-title":"J. Dermatol."},{"key":"10.1016\/j.crmeth.2026.101513_bib66","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1607-551X(09)70116-0","article-title":"In vitro activities of antibiotic combinations against clinical isolates of Pseudomonas aeruginosa","volume":"20","author":"Chen","year":"2004","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.crmeth.2026.101513_bib67","article-title":"Evaluation of different antibiotic actions combined with rifampicin: In vitro synergism against Pseudomonas and Proteus","volume":"21","author":"Perez Ure\u00f1a","year":"1975","journal-title":"Chemotherapy"},{"key":"10.1016\/j.crmeth.2026.101513_bib68","article-title":"Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections","volume":"63","author":"Chojnacki","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0420.2007.01006.x","article-title":"Acute bacterial conjunctivitis","volume":"86","author":"H\u00f8vding","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.crmeth.2026.101513_bib70","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0149-2918(95)80065-4","article-title":"Results of a survey of children with acute bacterial conjunctivitis treated with trimethoprim-polymyxin B ophthalmic solution","volume":"17","author":"Wagner","year":"1995","journal-title":"Clin. Ther."},{"key":"10.1016\/j.crmeth.2026.101513_bib71","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2015.12.007","article-title":"The antimicrobial susceptibility of non-tuberculous mycobacteria","volume":"72","author":"Cowman","year":"2016","journal-title":"J. Infect."},{"key":"10.1016\/j.crmeth.2026.101513_bib72","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","article-title":"The Rise of Non-Tuberculosis Mycobacterial Lung Disease","volume":"11","author":"Ratnatunga","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.crmeth.2026.101513_bib73","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/microorganisms7030090","article-title":"Mycobacterium abscessus: Environmental bacterium turned clinical nightmare","volume":"7","author":"Lopeman","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.crmeth.2026.101513_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00090-23","article-title":"Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus","volume":"67","author":"Van","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.diagmicrobio.2017.09.013","article-title":"In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex","volume":"90","author":"Zhang","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.crmeth.2026.101513_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011318","article-title":"The cell envelope of Mycobacterium abscessus and its role in pathogenesis","volume":"19","author":"Parmar","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.crmeth.2026.101513_bib77","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib78","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jac\/dkr016","article-title":"Comparative evaluation of synergy of combinations of \u03b2-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae","volume":"66","author":"Drago","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib79","article-title":"Endophthalmitis","author":"Simakurthy","year":"2023","journal-title":"StatPearls"},{"key":"10.1016\/j.crmeth.2026.101513_bib80","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1167\/iovs.16-19803","article-title":"Paucibacterial Microbiome and Resident DNA Virome of the Healthy Conjunctiva","volume":"57","author":"Doan","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.crmeth.2026.101513_bib81","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.1038\/s41598-017-10494-9","article-title":"Temporal Stability and Composition of the Ocular Surface Microbiome","volume":"7","author":"Ozkan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmeth.2026.101513_bib82","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF02849853","article-title":"Antibacterial Activity of the Fourth-Generation Fluoroquinolones Gatifloxacin and Moxifloxacin Against Ocular Pathogens","volume":"20","author":"Callegan","year":"2003","journal-title":"Adv. Ther."},{"key":"10.1016\/j.crmeth.2026.101513_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00562","article-title":"Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics","volume":"4","author":"Kapoor","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.crmeth.2026.101513_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02111-19","article-title":"Efficacy of antibiotic combinations against multidrug-resistant pseudomonas aeruginosa in automated time-lapse microscopy and static time-kill experiments","volume":"64","author":"Olsson","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9394(03)00896-1","article-title":"Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases","volume":"137","author":"Benz","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.crmeth.2026.101513_bib86","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1128\/AAC.39.5.1038","article-title":"Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"39","author":"Kumon","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib87","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s10156-002-0186-6","article-title":"Role of fosfomycin in a synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm","volume":"8","author":"Monden","year":"2002","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib88","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/jac\/dkw115","article-title":"Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance","volume":"71","author":"Walsh","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib89","doi-asserted-by":"crossref","first-page":"9705","DOI":"10.3390\/ijms24119705","article-title":"Mind the Curve: Dose\u2013Response Fitting Biases the Synergy Scores across Software Used for Chemotherapy Combination Studies","volume":"24","author":"Fuentealba-Manosalva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crmeth.2026.101513_bib90","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","article-title":"Microbiological spectrum and antibiotic sensitivity in endophthalmitis: A 25-year review","volume":"121","author":"Gentile","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.crmeth.2026.101513_bib91","article-title":"Single amino acid utilization for bacterial categorization","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmeth.2026.101513_bib92","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/CMR.00101-15","article-title":"Inhaled antibiotics for gram-negative respiratory infections","volume":"29","author":"Wenzler","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.crmeth.2026.101513_bib93","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-2600(22)00172-2","article-title":"Inhaled antibiotics for acute lower respiratory tract infections in primary care: a hypothesis","volume":"10","author":"Hay","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.crmeth.2026.101513_bib94","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A Novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of mycobacterium abscessus but is absent from mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmeth.2026.101513_bib95","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1513\/AnnalsATS.201501-015OI","article-title":"Mycobacterium abscessus: \u201cPleased to meet you, hope you guess my name","volume":"12","author":"Griffith","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.crmeth.2026.101513_bib96","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1513\/AnnalsATS.202003-222CME","article-title":"Summary for clinicians: 2020 clinical practice guideline summary for the treatment of nontuberculous mycobacterial pulmonary disease","volume":"17","author":"Kurz","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.crmeth.2026.101513_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126887","article-title":"Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence","volume":"253","author":"Nandanwar","year":"2021","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib98","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-024-07502-0","article-title":"A Gram-negative-selective antibiotic that spares the gut microbiome","volume":"630","author":"Mu\u00f1oz","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2026.101513_bib99","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/mbo3.1260","article-title":"Impact of antibiotics on the human microbiome and consequences for host health","volume":"11","author":"Patangia","year":"2022","journal-title":"Microbiologyopen"},{"key":"10.1016\/j.crmeth.2026.101513_bib100","doi-asserted-by":"crossref","first-page":"D401","DOI":"10.1093\/nar\/gkl858","article-title":"PATRIC: The VBI PathoSystems Resource Integration Center","volume":"35","author":"Snyder","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib101","doi-asserted-by":"crossref","first-page":"D366","DOI":"10.1093\/nar\/gks1241","article-title":"OrtholugeDB: a bacterial and archaeal orthology resource for improved comparative genomic analysis","volume":"41","author":"Whiteside","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib102","doi-asserted-by":"crossref","first-page":"D516","DOI":"10.1093\/nar\/gkae987","article-title":"OrthoDB and BUSCO update: annotation of orthologs with wider sampling of genomes","volume":"53","author":"Tegenfeldt","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib103","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkab966","article-title":"PhylomeDB V5: An expanding repository for genome-wide catalogues of annotated gene phylogenies","volume":"50","author":"Fuentes","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib104","doi-asserted-by":"crossref","first-page":"aad3292","DOI":"10.1126\/science.aad3292","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2026.101513_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/s44386-025-00034-1","article-title":"A review of deep learning approaches for drug synergy prediction in cancer","volume":"2","author":"Li","year":"2025","journal-title":"npj Drug Discov."},{"key":"10.1016\/j.crmeth.2026.101513_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s44386-026-00042-9","article-title":"A Metabolism-Informed Neural Network Identifies Pathways Influencing the Potency and Toxicity of Antimicrobial Combinations","volume":"3","author":"Arora","year":"2026","journal-title":"npj Drug Discov."},{"key":"10.1016\/j.crmeth.2026.101513_bib107","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41551-024-01201-x","article-title":"Deep-learning-enabled antibiotic discovery through molecular de-extinction","volume":"8","author":"Wan","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.crmeth.2026.101513_bib108","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/s41564-025-02061-0","article-title":"Deep learning reveals antibiotics in the archaeal proteome","volume":"10","author":"Torres","year":"2025","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib109","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"10.1016\/j.crmeth.2026.101513_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2021.101543","article-title":"New and simplified method for drug combination studies by checkerboard assay","volume":"8","author":"Bellio","year":"2021","journal-title":"MethodsX"},{"key":"10.1016\/j.crmeth.2026.101513_bib111","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Wayne","year":"2020"},{"key":"10.1016\/j.crmeth.2026.101513_bib112","series-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters","article-title":"The European Committee on Antimicrobial Susceptibility Testing","author":"EUCAST","year":"2020"},{"key":"10.1016\/j.crmeth.2026.101513_bib113","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cell.2010.11.052","article-title":"Phenotypic landscape of a bacterial cell","volume":"144","author":"Nichols","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.crmeth.2026.101513_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1023523","article-title":"Pseudomonas aeruginosa reference strains PAO1 and PA14: A genomic, phenotypic, and therapeutic review","volume":"13","author":"Grace","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.crmeth.2026.101513_bib115","doi-asserted-by":"crossref","first-page":"e8842","DOI":"10.1371\/journal.pone.0008842","article-title":"Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7","volume":"5","author":"Roy","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.crmeth.2026.101513_bib116","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B"}],"container-title":["Cell Reports Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237526002146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237526002146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:51:20Z","timestamp":1790002280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237526002146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":116,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2667237526002146"],"URL":"https:\/\/doi.org\/10.1016\/j.crmeth.2026.101513","relation":{},"ISSN":["2667-2375"],"issn-type":[{"value":"2667-2375","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TACTIC: A transfer learning framework to predict drug interactions in emerging pathogens","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2026.101513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101513"}}